PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy.
about
PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
PrLZ increases prostate cancer ...... LKB1/AMPK-mediated autophagy.
@en
PrLZ increases prostate cancer ...... LKB1/AMPK-mediated autophagy.
@nl
type
label
PrLZ increases prostate cancer ...... LKB1/AMPK-mediated autophagy.
@en
PrLZ increases prostate cancer ...... LKB1/AMPK-mediated autophagy.
@nl
prefLabel
PrLZ increases prostate cancer ...... LKB1/AMPK-mediated autophagy.
@en
PrLZ increases prostate cancer ...... LKB1/AMPK-mediated autophagy.
@nl
P2093
P2860
P356
P1433
P1476
PrLZ increases prostate cancer ...... LKB1/AMPK-mediated autophagy.
@en
P2093
P2860
P304
P356
10.7150/THNO.20356
P577
2018-01-01T00:00:00Z